TY - JOUR
T1 - Accelerated aging and young-onset cancer risk!-are stressors of the PELICan hypothesis the missing link?
AU - Barreto, Savio George
AU - Pandol, Stephen J.
PY - 2024/8/15
Y1 - 2024/8/15
N2 - At the 2024 Annual Meeting of the American Association for Cancer Research, researchers from Washington University in St. Louis (1) postulated a hypothesis that an increase in biological age reflective of accelerated aging could play a role in early-onset (cancers occurring in adults below the age of 55 years) carcinogenesis. They examined data from 148,724 individuals within the U.K. Biobank database. Each person’s biological age was calculated using the following biomarkers, including red cell distribution width, mean corpuscular volume, white blood cell count, lymphocyte proportion, blood: albumin, serum alkaline phosphatase, serum C-reactive protein, serum creatinine and serum glucose. They defined accelerated aging to be present when the person’s biological age exceeded their chronological age.
AB - At the 2024 Annual Meeting of the American Association for Cancer Research, researchers from Washington University in St. Louis (1) postulated a hypothesis that an increase in biological age reflective of accelerated aging could play a role in early-onset (cancers occurring in adults below the age of 55 years) carcinogenesis. They examined data from 148,724 individuals within the U.K. Biobank database. Each person’s biological age was calculated using the following biomarkers, including red cell distribution width, mean corpuscular volume, white blood cell count, lymphocyte proportion, blood: albumin, serum alkaline phosphatase, serum C-reactive protein, serum creatinine and serum glucose. They defined accelerated aging to be present when the person’s biological age exceeded their chronological age.
KW - accelerated biological aging
KW - young-onset cancer
KW - PELIcan hypothesis
KW - chronological aging
KW - Targeted therapies
UR - http://www.scopus.com/inward/record.url?scp=85200792347&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/2021009
U2 - 10.21037/cco-24-56
DO - 10.21037/cco-24-56
M3 - Letter
AN - SCOPUS:85200792347
SN - 2304-3865
VL - 13
JO - Chinese Clinical Oncology
JF - Chinese Clinical Oncology
IS - 4
ER -